Modifying an experimental system44,45 to enable interrogation of the effects of CTX drugs on cancer cells without the pleiotropic and confounding effects of CTX on non-tumor cells, we found that treatment-induced upregulation of the COX-2 pathway drives acute recruitment of circulating neutrophils and monocytes. The gene discussed is PTGS2; the disease is cancer.